Riyadh, Saudi Arabia — Alinma Bank has pledged SAR 6 million to support the Alinma Bank Baby Genome project, marking a major step for Saudi genetic research.
The agreement was signed under the patronage of His Royal Highness Prince Sultan bin Salman bin Abdulaziz. He serves as Chairman of the Board of Trustees at the King Salman Center for Disability Research.
This partnership comes through Alinma’s sustainability and social responsibility program, AMAD. It reflects the Bank’s commitment to promoting healthcare innovation and serving the community.
Alinma Bank Baby Genome Project: A First for Saudi Arabia
The Alinma Bank Baby Genome project is the first of its kind in the Kingdom and the region. It will provide full-genome sequencing for 1,000 newborns using advanced Whole-Genome Sequencing (WGS) technology.
This research spans all 13 regions of Saudi Arabia. Its goal is to detect genetic disorders early and reduce disease rates. Through early intervention, the project aims to enhance newborn survival and improve health outcomes.
The initiative will also establish a national genetic database. This resource will track hereditary patterns across the population and help advance future medical research.
Dr. Abdulmalik Abdullah Al-Hogail, Chairman of Alinma Bank, emphasized the value of this initiative. “We are proud to support this project,” he stated. “This partnership reflects Alinma’s dedication to serving humanity and delivering sustainable scientific solutions.”
Supporting Saudi Genome Research Through National Partnerships
The Alinma Bank Baby Genome project aligns with Saudi Arabia’s goals to improve healthcare and support research. It contributes to early diagnosis efforts and builds national expertise in genetic science.
This collaboration with the King Salman Center for Disability Research also reflects Alinma Bank’s role in supporting social responsibility programs. By combining financial support with scientific partnerships, the project promotes innovation in healthcare.
Saudi Arabia’s investment in newborn genome research strengthens the Kingdom’s leadership in preventive health. It also demonstrates how national initiatives can improve lives and protect future generations.
The Saudi Standard’s View: Advancing Newborn Health Through Innovation
The Baby Genome project marks a groundbreaking initiative that will strengthen Saudi Arabia’s capabilities in genetic research and newborn health. By enabling early diagnosis and targeted care, this program enhances national efforts to reduce the burden of genetic disorders.
Strategic partnerships like this, which combine financial support with scientific expertise, reflect Saudi Arabia’s broader vision of enhancing health outcomes through research, innovation, and sustainability.
Alinma Bank’s commitment to supporting this national endeavor reinforces the Kingdom’s leadership in developing future-focused, high-impact health solutions.
Explore Saudi Arabia’s leadership in genome research and newborn health
Discover how Alinma Bank’s CSR programs support Saudi healthcare innovation
